Craig Hallum reaffirmed their buy rating on shares of Encompass Health (NYSE:EHC) in a research note released on Tuesday morning, The Fly reports. They currently have a $60.00 price objective on the stock, up from their previous price objective of $54.00.
Separately, Bank of America upgraded shares of Encompass Health from an underperform rating to a neutral rating in a research note on Thursday, January 4th.
Shares of Encompass Health (NYSE EHC) traded down $0.39 during trading hours on Tuesday, hitting $49.67. 793,850 shares of the company were exchanged, compared to its average volume of 718,500. The company has a current ratio of 1.34, a quick ratio of 1.34 and a debt-to-equity ratio of 1.89. The company has a market capitalization of $5,158.37, a price-to-earnings ratio of 18.06, a PEG ratio of 1.81 and a beta of 0.54. Encompass Health has a fifty-two week low of $38.24 and a fifty-two week high of $52.58.
COPYRIGHT VIOLATION WARNING: “Encompass Health’s (EHC) “Buy” Rating Reaffirmed at Craig Hallum” was first published by Community Financial News and is owned by of Community Financial News. If you are reading this piece on another domain, it was illegally copied and republished in violation of international trademark and copyright legislation. The legal version of this piece can be viewed at https://www.com-unik.info/2018/01/10/encompass-healths-ehc-buy-rating-reaffirmed-at-craig-hallum.html.
Encompass Health Corporation, formerly HealthSouth Corporation, is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies.
What are top analysts saying about Encompass Health? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Encompass Health and related companies.